Faron Pharmaceuticals (UK) Market Value
| FARN Stock | 170.00 2.50 1.49% |
| Symbol | Faron |
Faron Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Faron Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Faron Pharmaceuticals.
| 01/25/2023 |
| 12/15/2024 |
If you would invest 0.00 in Faron Pharmaceuticals on January 25, 2023 and sell it all today you would earn a total of 0.00 from holding Faron Pharmaceuticals Oy or generate 0.0% return on investment in Faron Pharmaceuticals over 690 days. Faron Pharmaceuticals is related to or competes with Samsung Electronics, Samsung Electronics, Hyundai, Toyota, State Bank, SoftBank Group, and Reliance Industries. Faron Pharmaceuticals is entity of United Kingdom More
Faron Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Faron Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Faron Pharmaceuticals Oy upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 19.89 | |||
| Value At Risk | (5.26) | |||
| Potential Upside | 6.94 |
Faron Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Faron Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Faron Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Faron Pharmaceuticals historical prices to predict the future Faron Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.80) | |||
| Treynor Ratio | (0.42) |
Faron Pharmaceuticals Backtested Returns
Faron Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.1, which denotes the company had a -0.1% return per unit of risk over the last 3 months. Faron Pharmaceuticals Oy exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Faron Pharmaceuticals' Mean Deviation of 2.57, standard deviation of 3.69, and Variance of 13.59 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.81, which means possible diversification benefits within a given portfolio. As returns on the market increase, Faron Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Faron Pharmaceuticals is expected to be smaller as well. At this point, Faron Pharmaceuticals has a negative expected return of -0.37%. Please make sure to confirm Faron Pharmaceuticals' potential upside, kurtosis, and the relationship between the value at risk and skewness , to decide if Faron Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.31 |
Below average predictability
Faron Pharmaceuticals Oy has below average predictability. Overlapping area represents the amount of predictability between Faron Pharmaceuticals time series from 25th of January 2023 to 5th of January 2024 and 5th of January 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Faron Pharmaceuticals price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Faron Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | -0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 3298.08 |
Faron Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Faron Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Faron Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Faron Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Faron Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Faron Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Faron Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Faron Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Faron Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Faron Pharmaceuticals Lagged Returns
When evaluating Faron Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Faron Pharmaceuticals stock have on its future price. Faron Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Faron Pharmaceuticals autocorrelation shows the relationship between Faron Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Faron Pharmaceuticals Oy.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Faron Stock Analysis
When running Faron Pharmaceuticals' price analysis, check to measure Faron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Faron Pharmaceuticals is operating at the current time. Most of Faron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Faron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Faron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Faron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.